Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ketamine metabolite (2R,6R)-hydroxynorketamine reverses behavioral despair produced by adolescent trauma

Pharmacology Biochemistry and Behavior(2020)10.1016/j.pbb.2020.172973Source: DataRank Database

Ketamine metabolite (2R,6R)-hydroxynorketamine reverses behavioral despair produced by adolescent trauma is a research paper published in Pharmacology Biochemistry and Behavior (2020). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.87)OA: greenTopics (34)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Jenica D. Tapocik,Cheryl L. Mayo,Panos Zanos ORCID,Todd D. Gould ORCID,Gregory I. Elmer ORCID

Live enrichment

PubMed:32569786 PMC:PMC8386201 OpenAlex:https://openalex.org/W3036908632

U.S. Department of Veterans Affairs

Grant: 1I01BX004062

U.S. Department of Veterans Affairs

Grant: 101BX003631-01A1

National Institutes of Health

Grant: MH107615

BLRD VA

Grant: I01 BX003631

BLRD VA

Grant: I01 BX004062

NIMH NIH HHS

Grant: R01 MH107615

FWCI

1.87

Citation Percentile

0.8%

Citation Trend

2013

2020

2021

2022

2023

2025

2026

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8386201

publisherhttps://api.elsevier.com/content/article/PII:S0091305720301283?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0091305720301283?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.pbb.2020.172973

Fields of Study

Treatment of Major DepressionTryptophan and brain disordersNeuroscience and Neuropharmacology Research

MeSH Terms

AnimalsBehavior, AnimalDepressive Disorder, MajorMajor Depressive DisorderFemaleKetamineMaleMice, Inbred C57BLPredatory BehaviorStress, PsychologicalMice

Keywords

Learned helplessnessAntidepressantKetamineMajor depressive disorderPsychologyMetaboliteMedicineAdverse effectGlutamate receptorPharmacologyInternal medicinePsychiatryClinical psychologyReceptorHippocampusAmygdalaDepressionAdolescent Trauma(2R,6r)-hydroxynorketamine(2R,6r)-hnk

Sustainable Development Goals

SDG 0: Good health and well-being